Patent 10093927 was granted and assigned to University of Iowa on October, 2018 by the United States Patent and Trademark Office.
The present invention is directed to RNA interference (RNAi) molecules targeted against a nucleic acid sequence, and methods of using these RNAi molecules to reduce off-target toxicity.